BUENOS AIRES (Pakistan Point News / Sputnik - 21st September, 2021) Argentina's manufacturer of the Russian Sputnik V COVID-19 vaccine, the Richmond laboratory, will launch a new plant in a year for producing the Russian vaccine from scratch, laboratory CEO Marcelo Figueiras� said in an interview with Sputnik.
As of now, the active ingredient for production is supplied from Russia.
"We raised $85 million (in the market) to build a new vaccine production plant. We intend to carry our the entire Sputnik V production cycle there," Figueiras� said.
The new plant will also be equipped to produce RNA vaccines. The construction will cost $65 million, the rest of the raised funds will be invested in certification and clinical trials.
"The plant should be operational already in a year," Figueiras added, noting that construction is underway.
The Richmond laboratory chief plans to discuss the new plant and a potential long-term deal with the Russian Direct Investment Fund during his visit to Moscow in early October.
